Eli Lilly (LLY) Inventory (2009 - 2026)

Eli Lilly (LLY) has reported Inventory for 18 consecutive years, with $14.5 billion the latest figure, recorded in Q1 2026.

• Inventory for Q1 2026 came in at $14.5 billion, up 56.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.5 billion (up 56.04% YoY), and the FY2025 annual result was $13.7 billion, up 81.1% from the prior year.
• Inventory was $14.5 billion for Q1 2026 at Eli Lilly, up from $13.7 billion in the prior quarter.
• Over five years, Inventory peaked at $14.5 billion in Q1 2026 and troughed at $3.8 billion in Q3 2022.
• Average Inventory over 5 years is $7.3 billion, with a median of $6.1 billion recorded in 2024.
• Year-over-year, Inventory decreased 1.95% in 2022 and surged 81.1% in 2025.
• Over 5 years, Inventory stood at $4.3 billion in 2022, then soared by 33.95% to $5.8 billion in 2023, then soared by 31.46% to $7.6 billion in 2024, then soared by 81.1% to $13.7 billion in 2025, then increased by 5.71% to $14.5 billion in 2026.
• Per Business Quant data, the three most recent Inventory figures were $14.5 billion in Q1 2026, $13.7 billion in Q4 2025, and $12.2 billion in Q3 2025.